X

Trial Profile

Phase 1, Open Label, Single Arm Study to Evaluate the Safety, Tolerability and Efficacy of MPT0B640 in Patients With COVID-19 Infection

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I

Latest Information Update: 04 Jan 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs JIN 001 (Primary)
Indications COVID 2019 infections
Focus Adverse reactions
Sponsors J Ints Bio; Joseah Biopharma

Most Recent Events

08 Jun 2021 Status changed from not yet recruiting to withdrawn prior to enrolment.
08 Feb 2021 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.
08 Feb 2021 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com